| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |